immutep could be massive. Their lead scientist discovered LAG3. Their clinical programs in metastatic breast and head and neck cancer aren't that behind BMS with BMS data is in the crowded melanoma space. if LAG3 becomes the third space in check point Immunotherapies there could be a massive inflection in IMM SP. The leading global checkpoint inhibitor is Merck's Keytruda grew sales 30% to $14.4 billion USD annually in its last update, so any drug combination that keeps those type blockbuster programs relevant is incredibly valuable.
- Forums
- ASX - By Stock
- Ann: TACTI-002 and INSIGHT-004 abstracts for ASCO 2021
immutep could be massive. Their lead scientist discovered LAG3....
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.5¢ | $694.0K | 2.223M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 22530 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 176372 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 22530 | 0.310 |
21 | 379601 | 0.305 |
32 | 821817 | 0.300 |
9 | 158083 | 0.295 |
10 | 237886 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 176372 | 4 |
0.320 | 104699 | 4 |
0.325 | 108599 | 5 |
0.330 | 199775 | 4 |
0.335 | 196676 | 5 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online